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In sub-Saharan Africa, where the principle transmission route
of the human immunodeficiency virus (HIV) is heterosexual
sex, it is women and children who bear the greatest burden of
HIV infection. The rate of transmission per sex act from an
infected man to uninfected women is 3 times that from an
infected woman to an uninfected man, resulting in an HIV
prevalence ratio of 60% women to 40% men in many
communities.1 Children of HIV-infected mothers are exposed
in the womb, during labour and delivery and post-natally
through breastfeeding. If they become infected, disease
progression is more rapid than in adults,2 but potent anti-
retroviral therapy (ART) also greatly reduces mortality in
children living in low-income settings.3 In order to plan the
provision of ART to HIV-infected children in these settings,
information on the number of children needing such treatment
is required.
Estimating the need for ART
In this issue of the journal, Kirsty Little and colleagues4 present
a model to estimate the number of vertically infected children
that progress to moderate or severe disease and become eligible
for ART in South Africa. The model considers antenatal
prevalence, the risk of transmission before or at birth, infant
feeding policies and their associated risk of transmission, use of
co-trimoxazole to prevent opportunistic infections, use of ART
and mortality rates at different ages by disease stage and
according to treatment received. Background mortality rates
are inferred from the mortality rates of non-infected children of
HIV-positive mothers. Whilst the structure of the model
is comprehensive, some of the parameters are estimated from
a weak evidence base: the information comes from a pick-and-
mix of studies, and sometimes from a different geographical
area, as in the estimate of mortality of children on ART that is
taken from a study in Abidjan, Ivory Coast, but is applied to
South Africa.5 Fortunately, more data to inform such models
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are becoming available with the scale up of ART, and the
monitoring and evaluation that follows these initiatives.6
Treatment and prevention
In 2005, the peak HIV prevalence in South Africa was in
women aged 25–30, 40% of whom were infected.1 In some
places, such as Lesotho, prevalence has stabilized at 20% from
2000 onwards from which we can infer that the peak of
infections must have occurred around 4 years earlier.
Paradoxically, as ART is rolled out and less people die of
AIDS, prevalence will continue to rise even if incidence falls.
It is therefore crucial for monitoring incidence and future
trends to examine what happens in the youngest age groups,
children and 15 to 20-year-olds, which reflect newly acquired
infections. Modelling scenarios show that treatment will
never catch up with need if the current rate of incidence
of HIV infection holds.7 Therefore, to reverse the epidemic
a comprehensive package of prevention and treatment
measures are required. The need for treatment is acute.
Without access to ART, millions will die, but the future
course of the epidemic will be determined by how successful
prevention measures are, not by treatment.
Prevention of mother-to-child
transmission: missing targets
In industrialized countries, testing of pregnant women is
readily available, a combination of anti-retroviral drugs
is given prophylactically during pregnancy and to the newborn,
mothers can opt for delivery by elective caesarean and
breastfeeding is replaced by formula feeds. These measures
result in transmission rates <2%. In 2001, UNAIDS set global
targets to reduce mother-to-child transmission by 20% by
2005.8 What was achieved? It is estimated that the transmission
rate in the 33 countries most affected was 30% in 2001 and is
now 26%, a reduction of only 10%. The major problem is the
low coverage of anti-retroviral drug prophylaxis. The target set
by UNAIDS was 80% coverage, but no country had achieved
this by 2005 and overall only 9% of pregnant women had access
to prophylactic drugs. In sub-Saharan Africa, where 85% of
HIV-infected pregnant women live, coverage in countries ranges
from <1% to 54%.9
The lesser of two evils: breast is still best
About a third to one half of HIV-infected children acquired
their infection through breastfeeding.10 In high-income
countries this is prevented by replacing breastfeeding with
formula feeding. However, in low-income countries with high
burdens of infectious disease, breastfeeding has been ranked as
the most cost-effective intervention to improve child survival
and could prevent around 14% of infant deaths.11 During the
2006 floods in Botswana, there was a serious outbreak of
childhood diarrhoea and it was found that 93% of the children
admitted to hospital were not breastfed and these children were
at much higher risk of dying than breastfed children.12 Breast
milk is nutritionally superior to formula feed, is free, readily
available and protects against the diarrhoeal and respiratory
diseases that are often fatal in the first year of life.
The protective effect of breastfeeding will therefore outweigh
the potential harm from transmission of HIV in many resource-
limited settings. Of note, a recent cohort study from
KwaZulu-Natal, South Africa, showed that exclusive
breastfeeding for 6 months, that is, no additional fluids,
water or solids, is associated with a low transmission
rate (estimated at about 4% from 6 weeks to 6 months
after delivery).13
Education, education, education
Prevention in the youngest age group is also key to controlling
the epidemic. It has been pointed out that if each year birth
cohort only had sex with partners born in the same year, HIV
infection would die out.14 A common behaviour that drives the
epidemic is older men having sex with younger women. In
surveys of young people, those with secondary school education
were more likely to have a comprehensive knowledge of HIV
and AIDS compared with those with only primary education or
no education.3 Education tends to delay the age at which young
people first have sex and is associated with having fewer
partners and greater condom use. For girls in particular,
each year of education counts, giving them vital life skills,
knowledge and opportunity. Those who complete secondary
education know more about preventing HIV and what to do if
they think they are infected. They have more economic options
and independence, and are in a better position to make
informed choices about avoiding risky behaviour, negotiating
safer sex, delaying marriage and childbearing and having
healthier babies.
Unite for Children, Unite against AIDS
In 2005, UNICEF, UNAIDS and other partners launched the
Unite for Children, Unite against AIDScampaign,15 which targets
four key areas:
 Prevention of mother-to-child transmission.
 Provision of anti-retroviral treatment to children.
 Education and counselling programmes.
 Support for orphans and vulnerable children.
An interesting possible use of the model described by Little
et al.4 will be to evaluate the success of this campaign and its
components, and the model could also be extended to include
evaluation of different feeding strategies, including exclusive
breastfeeding, taking into account different burdens of other
infectious diseases. The monitoring and evaluating of the scale-
up of treatment and prevention using such models is crucial to
public health planning and the promotion of good practice.
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